Wintermute Biomedical are excited our ZosterEase Phase Ib clinical trial’s patient recruitment is now fulfilled.
Preliminary safety results expected shortly. Read more here.
Preliminary safety results expected shortly. Read more here.
Wintermute Publications
Wintermute Biomedical leverages over a decade of medical research to address infections with unmet needs. Explore our latest research and innovations in antimicrobial development and fatty acid technology.